Qvanteq completed ISO13485 Certification under the guidance of the notified body DEKRA. View Certificate.
Series B financing round Qvanteq AG today announced the successful completion of its series B financing round of 4 million Swiss Francs which has been raised from private investors. The funds will be used to obtain clinical proof of concept in a “First-in-Man” study as well as CE market approval for Qvanteq’s own novel coronary […]
Qvanteq AG was awarded with the “CTI Start-Up Label” in June 2012.
Qvanteq was among the finalists of the Pionierpreis 2012. 15 companies have been nominated.
A portrait of Qvanteq AG was published in the the Swiss journal “20minuten” under the the title “Weniger Herzinfarkte dank neuer Stent-Technologie”. Full article (g).